MTBC Pre-releases 60% YoY Revenue Growth and Selected

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
118
MTBC Pre-releases 60% YoY Revenue Growth and Selected Preliminary Q1 2017 Financial Results, Reaffirms Guidance

SOMERSET, NJ--(Marketwired - Apr 17, 2017) - MTBC ( NASDAQ : MTBC ) ( NASDAQ : MTBCP ), a leading provider of proprietary mHealth and cloud-based healthcare IT solutions, today pre-released selected preliminary, unaudited financial information for the three months ended March 31, 2017, and reaffirmed full year 2017 guidance.

MTBC expects its first quarter revenue to be approximately $8.2 million, which represents approximately 60% year-over-year revenue growth. Moreover, MTBC's GAAP net loss and non-GAAP adjusted EBITDA loss significantly improved in the first quarter of 2017 as compared to the fourth quarter of 2016. These financial results include the MediGain acquisition and are preliminary and subject to revision until the Company reports its first quarter results on May 10, 2017.

Mahmud Haq, Chairman and CEO of MTBC, said, "We are pleased to announce 60% revenue growth over the first quarter of 2016 and that we're on track for full year 2017 revenue of more than $30 million and full year 2017 adjusted EBITDA of $2.0 to $2.5 million." He continued, "Our organic sales initiatives are adding to the growth momentum from our 2016 acquisitions and we're also experiencing significant improvements in our margins as a result of the successful integration of our acquisitions."

MTBC guidance is summarized in the following table:

For the Fiscal Year Ending December 31, 2017 Forward Looking Guidance
Revenue $30 -  $31 million
Adjusted EBITDA $2.0 - $2.5 million

About MTBC Medical Transcription Billing, Corp. (MTBC) is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers practicing in a variety of practice sizes and settings. Our integrated Software-as-a-Service (or SaaS) platform helps our customers increase revenues, streamline workflows and make better business and clinical decisions, while reducing administrative burdens and operating costs. MTBC's common stock trades on the NASDAQ Capital Market under the ticker symbol "MTBC," and its Series A Preferred Stock trades on the NASDAQ Capital Market under the ticker symbol "MTBCP."

For additional information, please visit our website at www.mtbc.com .

Follow MTBC on TWITTER , LINKEDIN and FACEBOOK .

Use of Non-GAAP Financial Measures In our earnings releases, prepared remarks, conference calls, slide presentations, and webcasts, we may use or discuss non-GAAP financial measures, as defined by SEC Regulation G. The GAAP financial measure most directly comparable to each non-GAAP financial measure used or discussed, and a reconciliation of the differences between each non-GAAP financial measure and the comparable GAAP financial measure, are included in this press release after the condensed consolidated financial statements. Our earnings press releases containing such non-GAAP reconciliations can be found in the Investor Relations section of our web site at ir.mtbc.com.

Forward-Looking Statements This press release contains various forward-looking statements within the meaning of the federal securities laws. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as "may," "might," "will," "should," "intends," "expects," "plans," "goals," "projects," "anticipates," "believes," "estimates," "predicts," "potential," or "continue" or the negative of these terms or other comparable terminology.

Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, increased sales and marketing expenses, and the expected results from the integration of our acquisitions.

These forward-looking statements are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry's) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to: the Company's ability to manage growth; integrate acquisitions; effectively migrate and keep newly acquired customers and other important risks and uncertainties referenced and discussed under the heading titled "Risk Factors" in the Company's filings with the Securities and Exchange Commission.

The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.

SOURCE MTBC

Company and Investor Contact: Bill Korn Chief Financial Officer Medical Transcription Billing, Corp. bkorn@mtbc.com (732) 873-5133

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AppLovin Faces Legal Heat: Investors on Edge Today

Updated Category News Views 26

AppLovin's Day of Reckoning: Investors Take Note Ever find yourself caught in a whirlwind of corporate promises that slide into disappointment? Well, buckle up, because that's exactly where AppLovin finds itself today. They've stirred up a storm with investors over some questionable hyperbole about their artificial intelligence tools and ad services. Missteps and Market...

Continue Reading
Teledyne LeCroy Drives AI Scale-up with New UALink

Updated Category News Views 17

Pushing the Boundaries of AI Infrastructure Teledyne LeCroy is shaking things up with their latest innovation—the Xena Z2244 Ultra Accelerator Link™ Traffic Generator, a tool that promises to turbocharge validation systems for AI and HPC scale-up infrastructure. If you're dealing with the nuts and bolts of next-gen networks, this one's worth your attention. Setting a...

Continue Reading
Medtronic's Bold Move to Own Carotid Market Full-Scale

Updated Category News Views 150

When a giant like Medtronic makes a move, you can bet investors take notice, and this latest acquisition is no exception. They’re reaching into their deep pockets to acquire Contego Medical, a company shaking up the world of carotid artery disease treatments. It’s a tactical strike to solidify their leadership in cardiovascular solutions. Medtronic's Bet on Innovation...

Continue Reading
Atomera Preps for Key Craig-Hallum Conference

Updated Category News Views 59

Unpacking the NYC Gathering Alight, let's comb through the moving parts here. Atomera Inc., ticker NASDAQ: ATOM for those eyeing the dance of numbers, is all set to step into the limelight at the 17th Annual Craig-Hallum Alpha Select Conference on November 17, 2026. This shindig isn't just another date on the calendar; it's a strategic haunt where Atomera will rub...

Continue Reading
Mastering Prescription Labels: Critical Insights for Safety

Updated Category News Views 45

Revolutionizing How We Approach Prescription Labels Prescription labels aren't just scraps of paper or stickers slapped on bottles; they're lifelines. The insight from pharmacy expert Sheldon Birch could turn a regular label into a powerful tool for health management. According to Birch, the label is often disregarded yet speaks volumes about the medication you've got in...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 278

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Net Zero Efforts to Cost Europe €60B Annually by 2050

Updated Category News Views 100

Hefty Prices Loom Over Net Zero Commitments Well, strap in for a wallet buster, folks. Europe's largest players are staring down the barrel of a colossal €60 billion annual bill to clean up their carbon mess by 2050. That's the ticker in Senken's latest report, 'Pace of Change 2026.' Talks like these remind me there's no such thing as a free lunch, especially when...

Continue Reading
Biel Crystal Solidifies Position as Key iPhone UTG Supplier

Updated Category News Views 71

Biel Crystal Hones In On Foldable iPhone Tech Here's the lowdown: Apple's making waves with their first foldable phone, the iPhone Duo, and Biel Crystal? They're the rockstars cranking out that ultra-thin glass making it all possible. You might not have heard their name tossed around as much, but they're heavy hitters in the tech components scene. Biel Crystal's been...

Continue Reading
Africa Tech Festival 2026: A Digital Turning Point

Updated Category News Views 109

Setting the Stage for Digital Advancement in Africa Come mid-November, Cape Town's gonna be buzzing with the clatter of tech titans and financial honchos making their annual pilgrimage to the Africa Tech Festival. This ain't just a conference shindig—with names like Naspers, MTN, Meta, and Amazon on the docket, it's a darn convention shaping the continent's future...

Continue Reading
OFRM Faces Legal Heat Over Toddler Snack Recall

Updated Category News Views 12

OFRM Under the Microscope: Who Saw This Coming? Smack dab in the middle of navigating everyday market volatility, here's Once Upon A Farm (NYSE: OFRM) taking the spotlight—but for all the wrong reasons. The company got slapped with a stark FDA warning. Their Tractor Wheels toddler snacks allegedly pose a choking risk— think 'dry, sticky mass' refusing to budge with...

Continue Reading

Top 5 Most Recently Viewed Articles

Octopus AIM VCT plc Announces Securities Purchase Update

Updated Category News Views 173

Overview of Recent Securities Purchase by Octopus AIM VCT plc Octopus AIM VCT plc has made a significant move in the investment landscape with its recent transaction involving the purchase of its own securities. This strategic decision, which involved the cancellation of 723,329 ordinary shares, highlights the company's commitment to managing its capital structure...

Continue Reading
Bradford T Whitmore Makes Significant Investment in Ultralife

Updated Category News Views 116

Notable Insider Investment in Ultralife It recently came to light through official filings that Bradford T Whitmore, a Board Member of Ultralife (NASDAQ: ULBI), has made a substantial insider purchase. This move of buying shares resonates with his confidence in the company's growth trajectory. Understanding the Purchase Whitmore's investment entailed the acquisition of...

Continue Reading
Innovative Partnership to Enhance Youth Care in California

Updated Category News Views 202

Transforming Youth Care Through Innovation Qualifacts, a prominent leader in AI-driven electronic health record (EHR) software, has announced an exciting partnership with Open Line Group Homes. This collaboration aims to revolutionize the billing procedures and operational workflows within residential care facilities catering to youth. With the growing need for efficient,...

Continue Reading
Achilles Therapeutics Transfers Key Assets to AstraZeneca

Updated Category News Views 184

Achilles Therapeutics Transfers Key Assets to AstraZeneca - Proprietary data and samples from TRACERx and Achilles' Material Acquisition Platform (MAP) will be transferred to AstraZeneca under the Transaction - - Conclusion of Strategic Review - Recently, Achilles Therapeutics plc (ACHL) announced a pivotal deal, transferring the commercial license of essential data and...

Continue Reading
Insights into Opendoor Technologies (OPEN) Market Performance

Updated Category News Views 311

Recent Developments in Opendoor Technologies Stock Opendoor Technologies Inc (NASDAQ: OPEN) has been capturing investors' attention recently, showcasing a compelling rally that illustrates a resurgence of optimism. The stock, known for its dynamic trading patterns, experienced a significant upswing, climbing more than 50% within just a week. This movement brought its...

Continue Reading